Literature DB >> 15542938

Mouse models of atopic eczema critically evaluated.

Jan Gutermuth1, Markus Ollert, Johannes Ring, Heidrun Behrendt, Thilo Jakob.   

Abstract

Atopic eczema (AE) is a chronic relapsing inflammatory skin disorder with increasing prevalence in Western societies. Even though we have made considerable progress in understanding the cellular and molecular nature of cutaneous inflammation, the precise pathomechanisms of AE still remain elusive. Experimental animal models are indispensable tools to study the pathogenic mechanisms and to test novel therapeutic approaches in vivo. For AE a considerable number of mouse models have been proposed and have been used to study specific aspects of the disease, such as genetics, skin barrier defects, immune deviations, bacteria-host interactions or the role of cytokines or chemokines in the inflammatory process. While some models closely resemble human AE, others appear to reflect only specific aspects of the disease. Here we review the currently available mouse models of AE in light of the novel World Allergy Organization classification of eczematous skin diseases and evaluate them according to their clinical, histopathological and immunological findings. The pathogenetic analogies between mice and men will be discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15542938     DOI: 10.1159/000082099

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  10 in total

1.  Sulfuretin alleviates atopic dermatitis-like symptoms in mice via suppressing Th2 cell activity.

Authors:  Pingdong Jiang; Hui Sun
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

2.  Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin.

Authors:  Mei Li; Nadia Messaddeq; Marius Teletin; Jean-Louis Pasquali; Daniel Metzger; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

3.  Long-term Western diet intake leads to dysregulated bile acid signaling and dermatitis with Th2 and Th17 pathway features in mice.

Authors:  Prasant Kumar Jena; Lili Sheng; Kyle Mcneil; Thinh Q Chau; Sebastian Yu; Maija Kiuru; Maxwell A Fung; Samuel T Hwang; Yu-Jui Yvonne Wan
Journal:  J Dermatol Sci       Date:  2019-06-08       Impact factor: 4.563

4.  A novel hairless mouse model on an atopic dermatitis-prone genetic background generated by receptor-mediated transgenesis.

Authors:  Toyoyuki Takada; Hiroshi Shitara; Kunie Matsuoka; Erika Kojima; Rie Ishii; Yoshiaki Kikkawa; Choji Taya; Hajime Karasuyama; Kenji Kohno; Hiromichi Yonekawa
Journal:  Transgenic Res       Date:  2008-08-07       Impact factor: 2.788

5.  Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice.

Authors:  Matthew L Renninger; Rosemarie E Seymour; Laurence O Whiteley; John P Sundberg; Harm Hogenesch
Journal:  Exp Dermatol       Date:  2009-07-23       Impact factor: 3.960

Review 6.  Mast cells in atopic dermatitis.

Authors:  Toshiaki Kawakami; Tomoaki Ando; Miho Kimura; Bridget S Wilson; Yuko Kawakami
Journal:  Curr Opin Immunol       Date:  2009-10-14       Impact factor: 7.486

Review 7.  Translational Relevance of Mouse Models of Atopic Dermatitis.

Authors:  Justin Choi; Nishadh Sutaria; Youkyung Sophie Roh; Zachary Bordeaux; Martin P Alphonse; Shawn G Kwatra; Madan M Kwatra
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

8.  Indigo Pulverata Levis (Chung-Dae, Persicaria tinctoria) Alleviates Atopic Dermatitis-like Inflammatory Responses In Vivo and In Vitro.

Authors:  Ga-Yul Min; Ji-Hye Kim; Tae-In Kim; Won-Kyung Cho; Ju-Hye Yang; Jin-Yeul Ma
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

9.  Mast cells are required for full expression of allergen/SEB-induced skin inflammation.

Authors:  Tomoaki Ando; Kenji Matsumoto; Siavash Namiranian; Hirotaka Yamashita; Haley Glatthorn; Miho Kimura; Brandon R Dolan; James J Lee; Stephen J Galli; Yuko Kawakami; Colin Jamora; Toshiaki Kawakami
Journal:  J Invest Dermatol       Date:  2013-06-10       Impact factor: 8.551

10.  Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.

Authors:  Jarmila Knitlova; Vera Hajkova; Ludek Voska; Jana Elsterova; Barbora Obrova; Zora Melkova
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.